论文部分内容阅读
目的:研究老年妇科肿瘤合并2型糖尿病患者在围手术期予联合门冬胰岛素30治疗的临床效果。方法:对唐山工人医院自2008年11月至2012年11月以来收治的80例妇科肿瘤合并2型糖尿病患者进行回顾性分析,根据治疗方案不同分为A、B两组,每组40例。A组给予诺和灵R治疗;B组给予诺和锐治疗;对比两组日胰岛素的总量和血糖的控制情况,以及低血糖的发生率和临床并发症等发生情况。结果:两组患者经治疗1周其FBG与PBG 2 h全部调整达正常范围,而B组在24h内血糖控制的更为稳定,日胰岛素的用量较少,两组低血糖的发生率比较,差异无统计学意义(P>0.05)。结论:老年妇科肿瘤合并2型糖尿病患者在围手术期给予诺和锐治疗能够快速降低患者血糖,有效安全。
Objective: To study the clinical effects of perioperative combination of insulin aspart 30 in elderly gynecologic oncology patients with type 2 diabetes mellitus. Methods: A retrospective analysis of 80 gynecological tumor patients with type 2 diabetes treated in Tangshan Workers’ Hospital from November 2008 to November 2012 was divided into A and B groups, 40 cases in each group. Group A was treated with Novolin and R group; Group B was given NovoRay. The total amount of insulin and the control of blood glucose were compared between two groups. The incidence of hypoglycemia and clinical complications were also compared. Results: The two groups of patients after treatment for 1 week of FBG and PBG 2 h all adjusted to the normal range, while the B group within 24 hours of blood glucose control is more stable, the amount of daily insulin less, the incidence of hypoglycemia in both groups, The difference was not statistically significant (P> 0.05). Conclusion: Nuoherui treatment in elderly patients with type 2 diabetes mellitus and gynecologic oncology can rapidly reduce the blood sugar of patients with type 2 diabetes mellitus and is safe and effective.